WASHINGTON (dpa-AFX) - Moderna, Inc. (MRNA) announced on Tuesday that it has
been awarded a $176 million project grant through the Rapid Response Partnership
Vehicle, funded by BARDA within the U.S. Department of Health and Human Services
to expedite the development of mRNA-based pandemic influenza vaccines.

The company said that this funding will support the advanced stages of
development for an mRNA-based vaccine intended for the licensure of a
pre-pandemic vaccine targeting the H5 influenza virus, which is known to cause a
highly contagious and severe disease in birds and poses a potential risk of
transmission to humans.

The agreement also includes provisions for preparing and expediting responses to
future public health crises.



Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX